Study About Contrast Media

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Tartu

About this trial

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients 18 years or older

Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation

No peritonitis present, no need for an emergent surgery

Patients sign an informed consent

Disqualifiers

Patients younger than 18 yeas

Patients with mechanical small bowel obstruction caused by incarcerated hernias

Patients with mechanical small bowel obstruction caused by carcinomatosis

Patients with paralytic small bowel obstruction

Trial design

Design model

Parallel

Treatments tested in this trial

  • Effect on contrast media depending on the time of its administratsion

    Other intervention

    CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Contrast media 4 hoursActive comparator 1 intervention
Group B: Contrast media 24 hoursActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

SBO resolution

SBO resolution with conservative measures * passing gas * bowel movement * CM in the colon on the X-ray

Time frame
Period of hospitalization- approximately 5 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Tartu

Lead sponsor

North Estonia Medical Centre

Collaborator